Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
3 clinical trials · Condition
◉ Watch Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
| Record | Firm | Date |
|---|---|---|
| Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma (NCT07495735) | First Affiliated Hospital of Wenzhou Medical University | 2026-03-22 |
| Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals (NCT07088081) | Ain Shams University | 2025-06-01 |
| Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen) (NCT06416683) | University Hospital, Caen | 2021-01-01 |
Track Atezolizumab and Bevacizumab in Hepatocellular Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.